McKesson to Acquire Precision Medicine Group for $2.25 Billion

McKesson Corporation (NYSE: MCK) has signed a definitive agreement to acquire Precision Medicine Group for approximately $2.25 billion, expanding the... Read More

The post McKesson to Acquire Precision Medicine Group for $2.25 Billion appeared first on citybiz.